Posts Tagged ‘antipsychotics’

Meet the Queen of “Preschool Depression” — and Her Drug Company Backers

Monday, August 30th, 2010

by Jim Edwards

BNET August 30, 2010

The NYT Sunday magazine crowned Dr. Joan Luby as the queen of preschool depression this weekend, but failed to mention that Luby has taken cash from Johnson & Johnson (JNJ), Shire (SHPGY) and AstraZeneca (AZN) to study using atypical antipsychotics in young children. The article is significant because of the outsize role that the Times magazine plays in creating and naming new social trends. (Remember when you suddenly figured out that carbs make you fat but fatty meat doesn’t? That was the NYT mag.)

In this case, the phenomenon is depression in children as young as three years old, and the trend is to treat it with drugs such as Risperdal, Zyprexa, Adderall and Seroquel. The article, by Pamela Paul, provides a useful roadmap into how parenting will be medicalized by Big Pharma:

“The idea is very threatening,” says Joan Luby, a professor of child psychiatry  at Washington University School of Medicine, … “In my 20 years of research, it’s been slowly eroding,” Luby says of that resistance. “But some hard-core scientists still brush the idea off as mushy or psychobabble, and laypeople think the idea is ridiculous.”

The “ridiculous” layperson who first pointed out that Luby had written medical journal articles urging the use of antipsychotics on preschool children without declaring her drug company payments was me. Luby was a paid speaker for AstraZeneca in 2003-2004 (AZ makes Seroquel); she received $2019 in a for a consultancy from Shire in 2004 (Shire makes Adderall and Vyvanse); and prior to 2006 she received grant/research support from Janssen, the unit of J&J that markets Risperdal. Luby is also a member of a group of scientists who want greater study of potential new uses for psychiatric drugs in young children. That group has ties to 16 different drug companies. Some of these drugs have dangerous side effects.

The Archives of General Psychiatry (published by the American Medical Association) said it would investigate how Luby failed to disclose her past ties when it published “Preschool Depression,” a study she did on 3- to 6-year-olds. Joseph Coyle, the editor of the AGP, did not immediately respond to an email requesting an update on its Luby probe. (The American Psychiatric Association, which publishes the American Journal of Psychiatry, has chosen to ignore the issue.)

Read the rest of this article here:  http://www.bnet.com/blog/drug-business/meet-the-queen-of-8220preschool-depression-8221-8212-and-her-drug-company-backers/5595

To read about other pharma funded psychiatrists promoting a psycho/pharma agenda  read Shrinks For Sale – The Corrupt Alliance of the Psychiatric-Pharmaceutical Industry by CCHR   http://www.cchrint.org/cchr-issues/the-corrupt-alliance-of-the-psychiatric-pharmaceutical-industry/

Also read DSM Panel Members Still Getting Pharma Funds by CCHR http://www.cchrint.org/2010/05/21/dsm-panel-members-still-getting-pharma-funds/

« Return to news items


  • Share/Bookmark

Antipsychotic drugs double fatal pneumonia risk in elderly—drugs responsible for up to 1800 annual deaths in UK alone

Friday, August 27th, 2010

BBC News
August 27, 2010

The use of anti-psychotic drugs in the elderly doubles the risk of potentially fatal pneumonia, say Dutch researchers.

A study of almost 2,000 patients found the increased risk starts soon after treatment begins and concluded that patients should be closely monitored.

An expert review published in 2009 found the drugs are overused in many cases and are responsible for up to 1,800 deaths in the UK every year.

Ministers have said they want to see a significant cut in their use.

The latest research published in the Annals of Internal Medicine compared the health records of 258 over-65s with pneumonia with 1,686 patients without the infection.

Of those with pneumonia, a quarter died within a month.

When they looked at prescribed drugs, they found current use of anti-psychotics was associated with a roughly two-fold increase in the risk of pneumonia.

Those on the newer types of anti-psychotic drugs were slightly less likely to have the infection than those on the older class of drugs but were still at significant increased risk.

The risk was found to start soon after treatment and increased the higher the dose of drugs the patient was prescribed.

Read entire article here:  http://news.bbc.co.uk/2/hi/health/8599443.stm

« Return to news items


  • Share/Bookmark

People & Power—Drug Money

Tuesday, August 17th, 2010

A 23 minute TV expose on Big Pharma by ALJAZEERA (see video at bottom of this page)

This piece pulls no punches exposing the rampant fraud, fatal drug side effects, off label marketing, criminal practices  and “absolutely jaw dropping” payouts Pharma makes to psychiatrists/doctors.

  • “There is so much money to be made in stealing from the United States Healthcare system,” says Patrick Byrnes, Taxpayers Against Fraud.
  • Lewis Morris, US Department of Health states, “One of the things we are now looking at is going after the executives in these companies and holding them personally accountable.”
  • Sharon Ormsky, FBI Financial Crimes Unit states, “Pharmaceutical fraud is one of our top three threats — everybody is touched by these frauds in the extent that when you look at the billions of dollars that go into healthcare for the United States, a good percent,  3-10% of that is believed to be siphoned off into fraud—that’s  money that  could be going to very needy patients.”

Now the U.S. government is fighting back.  In the last two years alone, the  government has fined six of America’s  top ten pharmaceutical companies for fraud.  Investigations are ongoing against another three.  In this period the industry has had to pay out over 5 billion dollars in fines, and topping the list is drug giant Pfizer, having recently settled civil & criminal charges resulting in $2.3 billion dollars —the biggest fraud case, the biggest criminal case, the biggest false claims act in U.S. history.   ALJAZEERA also exposes Pfizer’s “interesting way of doing business.  Witnesses in the case revealed just how the company persuaded doctors to prescribe its drugs. It entertained them in strip clubs, it told them that the blues teenagers feel when they don’t make the football team was signs of treatable depression and it paid them to endorse Pfizer drugs. One doctor received $150,000 in a year.

Also highlighted is the current scandal regarding antipsychotic drugs, including state law suits, dangerous documented side effects and how federal investigators are now looking into claims drug company Johnson & Johnson illegally marketed their antipsychotic drug Risperdal to children, paying “some of the most influential doctors in the field” in order to accomplish this.  And leading that pack sits none other than the  [now] infamous psychiatrist Joseph Biederman, who has been “credited” with the huge increase of children prescribed psychiatry’s most powerful/dangerous drugs, antipsychotics, while receiving millions in Pharma kickbacks that he failed to disclose.   Biederman is shown on tape being questioned under oath, and when asked “What rank are you?” Biederman responds, “Full Professor.” When asked “What comes after that?” Biederman responds, “GOD.”

This is a 23 minute expose well worth watching.

This is one of the best exposé’s on Big Pharma we’ve seen:

People & Power —Drug Money, produced by ALJAZEERA.  This piece pulls no punches exposing the rampant fraud, fatal drug side effects, off label marketing, criminal practices  and “absolutely jaw dropping” payouts Pharma makes to psychiatrists/doctors.

* “There is so much money to be made in stealing from the United States Healthcare system,” says Patrick Byrnes, Taxpayers Against Fraud.

* Louis Morris, US Department of Health states, “One of the things we are now looking at is going after the executives in these companies and holding them personally accountable.”

*Sharon Ormsky, FBI Financial Crimes Unit states,  ”Pharmaceutical fraud is one of our top three threats — everybody is touched by these frauds in the extent that when you look at the billions of dollars that go into healthcare for the United States, a good percent,  3-10% is believed to be siphoned off into fraud that’s  money that  could be going to very needy patients.”

Now the U.S. government is fighting back.  In the last two years alone, the  government has fined six of America’s 10 pharmaceutical companies for fraud.  Investigations are ongoing into another three.  In this period the industry has had to pay out over 5 billion dollars in fines, and topping the list is drug giant Pfizer, having recently settled civil & criminal charges resulting in $2.3 billion dollars —the biggest fraud case, the biggest criminal case, the biggest false claims act in U.S. history.   ALJAZEERA also exposes Pfizer’s “interesting way of doing business.  Witnesses in the case revealed just how the company persuaded doctors to prescribe its drugs. It entertained them in strip clubs, it told them that the blues teenagers feel when they don’t make the football team was signs of treatable depression and it paid them to endorse Pfizer drugs. One doctor received $150,000 in a year.

Also highlighted is the current scandal regarding antipsychotic drugs, including state law suits, dangerous documented side effects and how federal investigators are now looking into claims drug company Johnson & Johnson illegally marketed their antipsychotic drug Risperdal to children, paying “some of the most influential doctors in the field” in order to accomplish this.  And leading that pack sits none other than the  [now] infamous psychiatrist Joseph Biederman, who has been “credited” with the huge increase of children prescribed psychiatry’s most powerful/dangerous drugs, antipsychotics, while receiving millions in Pharma kickbacks that he failed to disclose.   Biederman is shown on tape being questioned under oath, and when asked “What rank are you?” Biederman responds, “Full Professor.” When asked “What comes after that?” Biederman responds, “GOD.”

This is a 23 minute expose well worth watching.

http://www.youtube.com/watch?v=1TwdsYVHjGA&feature=player_embedded#!

This is one of the best exposé’s on Big Pharma we’ve seen:

People & Power —Drug Money, produced by ALJAZEERA.  This piece pulls no punches exposing the rampant fraud, fatal drug side effects, off label marketing, criminal practices  and “absolutely jaw dropping” payouts Pharma makes to psychiatrists/doctors.

* “There is so much money to be made in stealing from the United States Healthcare system,” says Patrick Byrnes, Taxpayers Against Fraud.

* Louis Morris, US Department of Health states, “One of the things we are now looking at is going after the executives in these companies and holding them personally accountable.”

*Sharon Ormsky, FBI Financial Crimes Unit states,  ”Pharmaceutical fraud is one of our top three threats — everybody is touched by these frauds in the extent that when you look at the billions of dollars that go into healthcare for the United States, a good percent,  3-10% is believed to be siphoned off into fraud that’s  money that  could be going to very needy patients.”

Now the U.S. government is fighting back.  In the last two years alone, the  government has fined six of America’s 10 pharmaceutical companies for fraud.  Investigations are ongoing into another three.  In this period the industry has had to pay out over 5 billion dollars in fines, and topping the list is drug giant Pfizer, having recently settled civil & criminal charges resulting in $2.3 billion dollars —the biggest fraud case, the biggest criminal case, the biggest false claims act in U.S. history.   ALJAZEERA also exposes Pfizer’s “interesting way of doing business.  Witnesses in the case revealed just how the company persuaded doctors to prescribe its drugs. It entertained them in strip clubs, it told them that the blues teenagers feel when they don’t make the football team was signs of treatable depression and it paid them to endorse Pfizer drugs. One doctor received $150,000 in a year.

Also highlighted is the current scandal regarding antipsychotic drugs, including state law suits, dangerous documented side effects and how federal investigators are now looking into claims drug company Johnson & Johnson illegally marketed their antipsychotic drug Risperdal to children, paying “some of the most influential doctors in the field” in order to accomplish this.  And leading that pack sits none other than the  [now] infamous psychiatrist Joseph Biederman, who has been “credited” with the huge increase of children prescribed psychiatry’s most powerful/dangerous drugs, antipsychotics, while receiving millions in Pharma kickbacks that he failed to disclose.   Biederman is shown on tape being questioned under oath, and when asked “What rank are you?” Biederman responds, “Full Professor.” When asked “What comes after that?” Biederman responds, “GOD.”

This is a 23 minute expose well worth watching.

« Return to news items


  • Share/Bookmark

Overmedication contributes to military suicides, advocates say

Thursday, August 12th, 2010
By Veronica Nett
The Charleston Gazette

CHARLESTON, W.Va. — The suicide rate among military veterans has ballooned in recent years, in part because of overmedication of service members and a lack of support for veterans, advocates for treatment of Post Traumatic Stress Disorder said Thursday.

Psychiatrists sometimes prescribe drugs as a cure without an actual understanding of what the drugs do, said Dr. Peter R. Breggin, a psychiatrist and author from Ithaca, N.Y.

In 2008, the Army’s suicide rate — 20.2 per 100,000 — exceeded the civilian suicide rate for the first time. The civilian suicide rate has held steady for years at about 18 per 100,000, according to the U.S. Department of Defense.

Breggin and seven panelists addressed a crowd of about 50 therapists, social workers, members of the state Veterans Affairs department, in addition to service members and their families at the 2010 PTSD and Traumatic Brain Injury Education and Awareness Conference.

Care-Net, a branch of the state Council of Churches, sponsored the conference at the Blessed John XXIII Pastoral Center in Charleston.

PTSD is the brain’s natural reaction to extreme stress and traumatizing experiences, said Breggin, the conference’s keynote speaker. Tramuatic brain injury looks just like PTSD, he said.

“There is no drug that improves the function of the brain,” said Breggin, who said he will not prescribe psychiatric drugs as treatment for any disorder.

Psychiatric drugs, such as antidepressants and anxiety medication, alter the chemical balance in the brain, disrupt the release of serotonin and, in many cases, have the same effect as street drugs, Breggin said.

Patients using psychiatric drugs have experienced psychotic and violent behavior, attempted suicide and are unable to think clearly, Breggin said.

Mary Lahas talked about her son, Michael, who she said stuck IV needles into his arms in a suicide attempt.

Her son, an Army infantry member, survived roadside bomb explosions, and witnessed the shooting death of civilians in Iraq, Lahas said Thursday.

He returned from his first deployment in 2008 with PTSD and TBI and suffered from headaches, anxiety, guilt, tinnitus and memory problems, Lahas said. He refused to seek help, she said, because he saw other soldiers ridiculed who did.

When he finally did seek help, he was given a “cocktail of death,” that included antidepressants, anxiety medications and sleep aids, Lahas said.

“He was so overmedicated he could not care for himself — eat, sleep or brush his teeth,” she said.

The drugs and stress led him to try to take his own life, and while standing in his bathroom bleeding, he drew a smiley face on the wall in his own blood, she said.

Read the rest of this article here: http://wvgazette.com/News/201008120975

« Return to news items


  • Share/Bookmark

WW market for antipsychotics to reach $20.8 bil—hence the heavy PR/marketing of ‘schizophrenia’—its a lucrative market

Thursday, August 12th, 2010

PR Newswire
August 10, 2010

Reportlinker.com announces that a new market research report is available in its catalogue:

Antipsychotic Drugs: Technologies and Global Markets

The total worldwide market for antipsychotic drugs is expected to reach $19.6 billion in 2010.  With continued market penetration into new diseases and price increases for currently marketed antipsychotics, this market is expected to grow to a high of $20.8 billion in 2011 and then hit a low of $14.4 billion in 2013, before resuming growth again to $14.8 billion in worldwide sales for 2014. This represents a total compound annual growth rate (CAGR) of -4.6%.

Most atypical antipsychotics will lose patent exclusivity through the study period, resulting in a compound annual growth rate (CAGR) of -3.7%. This market will be worth an estimated $18.5 billion by the end of 2010, but decrease to $14.5 billion in 2014.

Read entire article here:  http://www.prnewswire.com/news-releases/reportlinker-adds-antipsychotic-drugs-technologies-and-global-markets-100343619.html

« Return to news items


  • Share/Bookmark

Long Awaited Army Report on Suicides Ignores Role of Suicide-Causing Drugs such as Antidepressants/Antipsychotics

Monday, August 2nd, 2010

OpEdNews
By Martha Rosenberg
August 1, 2010

Why are troops killing themselves?

The long awaited Army report, “Health Promotion, Risk Reduction, Suicide Prevention” considers the economy, the stress of nine years of war, family dislocations, repeated moves, repeated deployments, troops’ risk-taking personalities, waived entrance standards and many aspects of Army culture.

What it barely considers is the suicide-inked antidepressants, antipsychotics and antiseizure drugs whose use exactly parallels the increase in US troop suicides since 2005.

In the report Chief of Staff General Peter W. Chiarelli acknowledges antidepressant risks, saying there’s “fair quality evidence that second generation antidepressants (mostly SSRI) increase suicidal behavior in adults aged 18 to 29 years” but adds that “other research evidence shows the benefit of antidepressant use”.

And nowhere does he acknowledge the suicide potential of antiseizure drugs so widely used for pain and as “mood stabilizers” by troops even though the FDA mandated suicide warnings on Lyrica, Topamaz, Depakote, Lamictal, Tegretol, Depakene, Klonopin and 16 others in 2008.

(Lamictal also has the distinction of wasting more taxpayer money than any other drug according to a July American Enterprise Institute report. Medicaid spent an unnecessary $51 million on Lamictal instead of buying a generic last year, thanks to GSK salesmen. You go, guys,)

When asked by NPR’s Robert Siegel if the high number of medicated troops contributed to suicide, Gen. Chiarelli said, “The good thing about those numbers is…the prescriptions were all made by a doctor.” Asked why troops who had not even deployed were among the suicides, Chiarelli said there were other stressors involved.

In June Marine Times reported 32 deaths on prescription drugs in Warrior Transition Units (WTUs) since 2007 and said an internal review “found the biggest risk factor may be putting a soldier on numerous drugs simultaneously, a practice known as polypharmacy.”

But instead of citing dangerous drugs and drug cocktails for turning troops suicidal (and accident prone and at risk of death from unsafe combinations) the Army report cites troops’ illicit use of them along with street drugs. (The word “illicit” appears 150 times in the Army report and “psychiatrist” appears twice.)

No, it’s not the 8,000 urine samples in 2009 which showed prescription drug traces according to the Army report — it’s the fact that 21 percent of the drugs were “illicit.”

No wonder the revised suicide report form suggested by the Army report doesn’t even have a box to enter “adverse reactions to drug or drug combinations.” Instead, it has a box that asks how long before a suicide a patient was “compliant” with the prescription. Was the medication “taken as prescribed? Skipped?” Taken “In excess of prescription? In different manner (e.g., crushed instead of in capsule)?”

Read entire article here:  http://www.opednews.com/articles/Army-Suicide-Report-Ignore-by-Martha-Rosenberg-100801-596.html?show=votes

« Return to news items


  • Share/Bookmark

Austrailan Psychiatrist Patrick McGorry’s Global Agenda for “Pre-Psychosis Risk Syndrome” Takes A Hit from Former DSM Task Force Member, Psychiatrist Allen Frances

Friday, July 30th, 2010

Note: The diagnosis being pushed for global implementation, “Pre-Psychosis Risk Syndrome” by “Australian of the Year,” Psychiatrist Patrick McGorry, takes a hit from a worthy opponent, Psychiatrist Allen Frances, former Chairiman of the DSM Task force. For more information about Patrick McGorry’s global agenda, click here:http://www.cchrint.org/2010/06/16/australian-psychiatrist-patrick-mcgorry-wants-his-pre-drugging-agenda-to-go-global/

DSM5 in Distress
Psychology Today
by Allen Frances, MD

The DSM 5 Workgroup that first suggested the inclusion of “Psychosis Risk Syndrome” has halfway come to its senses. It has dropped this stigmatizing name in a last ditch repackaging effort to salvage the proposal. The criteria set remains essentially the same, but is relabeled with the equally awkward title: “Attenuated Psychotic Symptoms Syndrome”. The suggestion remains just as dangerous and stigmatizing, whatever it is called.

Why the halfway reversal by the Workgroup at this late date? The “Psychosis Risk” proposal has stimulated widespread opposition (even I am told from within the Workgroup itself). The arguments against it are simply overwhelming. The false positive rate in predicting psychosis would be between 70-90%, meaning that between two and nine youngsters would be misidentified for every one accurately identified. The treatment most likely to be used would be antipsychotic medications. These have no proven efficacy in preventing psychosis, but most definitely have terrible side effects- especially enormous weight gain and its life threatening complications. These medications are overprescribed to those least able to resist- the young and those who are most financially disadvantaged.

Finally, the name “Psychosis Risk” was filled with ominous threat and stigma. Having a label that suggests one is at risk to soon develop a psychosis would cause the mislabelled person much unnecessary worry, unnecessarily reduced ambitions, and create great risk of discrimination in getting work or insurance – thus further exacerbating the risk side of the already totally unbalanced risk-benefit ratio.

As an early intervention strategy, everything that could possibly be wrong was wrong with “Psychosis Risk Syndrome”. An extremely inaccurate diagnosis would lead to widespread treatment with an ineffective but dangerous medication. To top it off, the writing of the criteria set is remarkably vague and internally inconsistent. That “Psychosis Risk” was an obvious nonstarter finally got through to the DSM 5 Work Group.

Seemingly, this should have been an end of story moment and we could all breathe a sigh of relief. The obvious and correct next step would be to withdraw the proposal for official recognition and instead relegate Psychosis Risk to where it belongs- in the DSM 5 appendix of suggestions that require further research. Instead, the Work Group is trying to save the suggestion by changing its name and ditching some of its overly ambitious claims.

The idea is to avoid the criticism regarding the high false positive rate by withdrawing claims that the “patients” described are likely to go on to psychosis and that the risk syndrome diagnosis can help to prevent this outcome. But the diagnosis now rests on a new set of equally questionable assumptions, that-1) the people described would have come for treatment anyway; 2) there will be no increase in overall diagnosis, just more accurate diagnosis;
3) inappropriate antipsychotic use can be contained by physician education; and, 4) the new name will carry less stigma.
.
The Work Group has always been well intentioned, but is as dead wrong in its new claims as it was in its old. Were this diagnosis to be made official- however renamed – it would certainly be used (and probably widely misused) to diagnose youngsters who previously would have avoided diagnosis and treatment. Particularly given the imprecise writing of the criteria set, it will mislabel many teenagers- especially those who are using substances, but also those who are creative or eccentric, and/or have difficult relationships with their parents. The experts on the Workgroup might make these mistakes infrequently, but they can’t responsibly make suggestions that are usable only by experts like themselves. Once official, the diagnosis will be misused in ways they never imagined or would accept and will lead to even greater misuse of antipsychotics. And the Work Group can’t rely on the wonders of physician education to clean up the mess they will be making. Most of the physician education will come from the very drug companies that have already shown themselves remarkably adept at furthering the overprescription of antipsychotics to children and teenagers.

Read the rest of the article here: http://www.psychologytoday.com/blog/dsm5-in-distress/201007/psychosis-risk-syndrome-just-risky-new-name

More information on Patrick McGorry and Pre Psychosis Risk Syndrome: http://www.cchrint.org/2010/05/21/meet-the-psychiatrist-pushing-for-a-brave-new-world-of-pre-drugging-kids%E2%80%94patrick-mcgorry/

http://www.cchrint.org/2010/06/16/australian-psychiatrist-patrick-mcgorry-wants-his-pre-drugging-agenda-to-go-global/

http://www.cchrint.org/2010/06/29/pre-crime-try-pre-diagnose-and-pre-drug-psychiatrists-target-infants-as-mental-patients-2/

« Return to news items


  • Share/Bookmark

Psychiatric Meds 101—A layman’s guide to drug side effects—by award winning Scientist Shane Ellison

Wednesday, July 21st, 2010

By Shane “The People’s Chemist” Ellison
Author, Over-The-Counter Natural Cures

I may be a perfect candidate for psychiatry.

I ask questions with period marks to shorten conversations. I avoid eye contact with strangers in fear (maybe it’s anxiety) that I might learn too much about them. I secretly think that Metallica would be making better music if they went back to bludgeoning themselves with party drugs and alcohol, instead of “therapy.” I’m trying to master the Law of Un-attraction to shield myself from a “real job,” small homes and junky cars.  And, I’m constantly giving my children advice, only to give it to myself.

Psychiatry, can your drugs help me?

Perhaps these questions are what motivated me to pursue a career as a drug design chemist, winning multiple awards for my work. Nothing gets me more excited than drugs and how they affect the body (except my wife’s abs). I’ve studied their molecular anatomy, risked life and limb to mix and match explosive chemicals in a round bottom flask, and even sold my soul to Big Pharma in exchange for a lab bench and chemical hood.

During this time, I’ve made some surprising discoveries about psychiatric meds, which include antidepressants, antipsychotics, stimulants, and anti-anxiety drugs. Understanding what I’ve learned will protect you from the flood of side effects that are now being discovered at breakneck speeds, courtesy of the myriad of patients being prescribed psychiatric drugs in the name of mental health.

Your Own Personal Hell

Antidepressants strive to increase the levels of a “coping” molecule known as serotonin in the brain. It supposedly helps us find happiness when it’s covered in an avalanche of nastiness. But, it’s never been proven. Still, the drugs attempt to boost serotonin by “selectively” stopping the “reuptake” among brain cells. This is where the whole SSRI acronym came from—“selective serotonin reuptake inhibitor.” It’s a slick name, but a stupid idea. Nothing is selective in the body.

Read the rest of this article here: http://www.cchrint.org/2010/07/20/psychiatric-meds-101-a-surprising-discovery/

« Return to news items


  • Share/Bookmark

Psychiatric Meds 101: A Surprising Discovery

Tuesday, July 20th, 2010

By Shane “The People’s Chemist” Ellison
Author, Over-The-Counter Natural Cures

I may be a perfect candidate for psychiatry.

I ask questions with period marks to shorten conversations. I avoid eye contact with strangers in fear (maybe it’s anxiety) that I might learn too much about them. I secretly think that Metallica would be making better music if they went back to bludgeoning themselves with party drugs and alcohol, instead of “therapy.” I’m trying to master the Law of Un-attraction to shield myself from a “real job,” small homes and junky cars.  And, I’m constantly giving my children advice, only to give it to myself.

Psychiatry, can your drugs help me?

Perhaps these questions are what motivated me to pursue a career as a drug design chemist, winning multiple awards for my work. Nothing gets me more excited than drugs and how they affect the body (except my wife’s abs). I’ve studied their molecular anatomy, risked life and limb to mix and match explosive chemicals in a round bottom flask, and even sold my soul to Big Pharma in exchange for a lab bench and chemical hood.

During this time, I’ve made some surprising discoveries about psychiatric meds, which include antidepressants, antipsychotics, stimulants, and anti-anxiety drugs. Understanding what I’ve learned will protect you from the flood of side effects that are now being discovered at breakneck speeds, courtesy of the myriad of patients being prescribed psychiatric drugs in the name of mental health.

Your Own Personal Hell

Antidepressants strive to increase the levels of a “coping” molecule known as serotonin in the brain. It supposedly helps us find happiness when it’s covered in an avalanche of nastiness. But, it’s never been proven. Still, the drugs attempt to boost serotonin by “selectively” stopping the “reuptake” among brain cells. This is where the whole SSRI acronym came from—“selective serotonin reuptake inhibitor.” It’s a slick name, but a stupid idea. Nothing is selective in the body.

While trying to block the reuptake of serotonin, antidepressants can also prevent its release and that of another brain compound known as dopamine. The areas of the brain responsible for release and reuptake of these neurotransmitters are so damn similar (after all, they work on the same molecule) that an antidepressant drug isn’t smart enough to understand which one it is supposed to work on. So it does what any dumb drug would do, it blocks both. That’s why users usually carry a glassy stare in their eye. Fully under the psychiatric spell, they’ve tuned out.

Deep sadness, fear, anger and aggression can set in over time. By removing serotonin and dopamine from the brain, long-term antidepressant users can’t find or feel happiness. Instead, they may become buried in the avalanche of nastiness. And if you can’t find or feel happiness in life, what’s the point? What’s going to stop you from snapping your own neck or spraying bullets on your classmates? Not much when you live in your own personal antidepressant hell.

Think this is all opinion?

According to the FDA, antidepressants can cause suicidal thoughts and behavior, worsening depression, anxiety, panic attacks, insomnia, irritability, hostility, impulsivity, aggression, psychotic episodes and violence.  Some even cause homicidal ideation according to the manufacturers. Many long-term antidepressant users will tell you they no longer feel normal emotions—they’re numb, like zombies.

But the side effects of these drugs aren’t limited to hijacking your feelings and emotional state, causing violent and psychotic states. Physical side effects occur too and include abnormal bleeding, birth defects, heart attack, seizures and sudden death. Over one hundred and seventy drug regulatory warnings and studies have been issued on antidepressants, to sound the alarm on these side effects.

For Elephant Use Only

Psychiatrists prescribe antipsychotic meds such as Zyprexa and Seroquel, for anything from schizophrenia, bipolar disorder, delusional disorder, psychotic depression, autism or anything else they can think of, even “pervasive developmental disorder,” which is perfect for boosting sales because it targets children who suffer from irritability, aggression, and agitation. It’s a shame ‘cause these drugs are good for nothing but sedating irate elephants, not curing psychiatric disease.

According to a study published in Psychological Medicine, antipsychotic drugs cause brains to shrink – they lessen brain matter and volume. Originally designed for those deemed “schizophrenic,” the drug companies came up with a brilliant marketing campaign to sell these drugs to a much wider market—unsatisfied antidepressant users. You’ve probably seen the ads—if your “depression medication” isn’t working, then don’t blame the drug; you may just have bipolar disorder!

Once swallowed, antipsychotics sail through the blood stream where they’re carried to the brain. Like a giant oil spill, antipsychotics cover the brain in a medicinal slick, where brain wave transmission is blocked. Users become devoid of normal brain activity. Motivation, drive and feelings of reward are shunted. If psychiatry considers this a “treatment,” they’re the crazy ones.

If you’ve ever seen someone who has suffered from the “spill” courtesy of following doctors orders, you can’t mistake one of the most common side effects, it’s called Akathisia. Involuntary movements, tics, jerks in the face and the entire body can become permanent side effects for antipsychotic users.

Antipsychotics also cause obesity, diabetes, stroke, cardiac events, respiratory problems, delusional thinking and psychosis. Drug regulators from the U.S., Canada, United Kingdom, Ireland, Australia, New Zealand and South Africa warn that they can also lead to death. I wouldn’t be surprised if psychiatrists considered this a cure…

Use This to Jump The Grand Canyon

If you’re going to attempt to jump your scooter over the Grand Canyon, or ride your snowboard off Kilimanjaro, stimulants are great. They flood the brain with dopamine and trigger an inhuman surge of adrenaline, responsible for making you believe life is grand, despite eminent death. Outside of that, you’re either a speed freak, a college student trying to learn an entire semester of Biology 101 in 4 hours, or a fifth grader “following doctor’s orders.”

Top stimulants being prescribed today are nothing more than a mix of amphetamines packaged into trade names like Adderall, Dexedrine and Ritalin.  Street thugs sell it as meth, poor man’s cocaine, crystal, ice, glass and speed. It’s no wonder kids are now abusing Ritalin, Adderall and these drugs more than street drugs, they’re cheaper to get and they’re “legal,” hence the term kiddie cocaine.

Even the U.S. Drug Enforcement Administration (DEA) categorizes Ritalin in the Schedule ll category, meaning a high potential for abuse—just like cocaine and morphine. All of them have the same effects regardless of how they’re named: Central nervous system overload leading to heart attack and/or heart failure. And kids are dropping faster than Meth Heads at Raves…

I’m not exaggerating.

Eleven international drug regulatory agencies and our own FDA has issued warnings that stimulants like Ritalin cause addiction, depression, insomnia, drug dependence, mania, psychosis, heart problems, stroke and sudden death.

Bash Your Head in with Anti-Anxiety Drugs

If you’re not man enough for a drug that could sedate an elephant like antipsychotics, then psychiatrists will prescribe anti-anxiety meds, particularly benzodiazepines. Choosing between the two is akin to deciding whether or not you should be hit in the head with an aluminum bat or a wooden one; anti-anxiety meds being the latter.

Discovered in the stinky chemistry labs of Hoffman La Roche in 1955, anti-anxiety meds aim to trigger sleep receptors in the brain, just slightly. So, rather than being riddled with anxiety, you are put to sleep, halfway. It’s “treatment,” and psychiatrists have been “practicing it for decades.” But, it has yet to work, because drugging your problems away is more dangerous than anxiety. The use of anti-anxiety meds is coupled with a host of nasty side effects such as seizures, aggression and violence once the drug wears off. Hallucinations, delusional thinking, confusion, abnormal behavior, hostility, agitation, irritability, depression and suicidal thinking are all possible outcomes according to Big Pharma’s heavily guarded research papers.

Getting off the drugs could be harder than abandoning a heroin addiction. Some have described withdrawal from “benzos” being akin to pulling hundreds of fish hooks out of their skin, without anesthesia. If you doubt their addictive nature, go to Google search and type in a few of the leading anti-anxiety drugs like Klonopin or Xanax and here is what you’ll find:

“Klonopin withdrawal” 1,860,000 results

“Xanax withdrawal” 1,980,000 results

Exposing Psychiatry: How to Get The Truth

In total, the side effects of psychiatric meds spread far and wide. And most are hidden from patients and doctors alike. Fortunately, Citizens Commission on Human Rights has solved this problem with a state-of-the-art database that allows people to search through the adverse reaction reports sent to the FDA on psychiatric drugs. It also provides international drug regulatory agency warnings and studies published on the side effects of the drugs.

So, can psychiatry help me? No. And that’s surprising because psychiatric meds are some of the biggest selling drugs, poised to seal the hopes and dreams of millions.  Regardless of what mental state I might be in (or anyone else for that matter), there is not a single drug that cures, treats or solves the perceived problems of mental health.

While people can suffer miserably from emotional or mental duress that can hinder their lifestyle, the pseudo-science of psychiatry has yet to solve any of these problems, and in fact only contributes to poor health as seen by the wide array of side effects. Marketing campaigns and ghostwritten medical journals are designed to obscure these facts. But the psychiatric drug side effect database courtesy of CCHR ensures that all patients have access to the truth, to the documented facts, which could save their life or that of a loved one.

About the Author

Shane Ellison holds a masters degree in organic chemistry and is the author of Over-The-Counter Natural Cures.  An award winning chemist, he has been quoted by USA Today, Shape, Woman’s World, as well as Women’s Health and appeared on Fox and NBC as a natural medicine advocate.  Sample his book free at www.thepeopleschemist.com

To use this slideshow on your own website, you can use one of these two embed codes:

<object data=”http://www.cchrint.org/slideshow/index.html” width=”593″  height=”440″ style=”overflow:hidden; height:440px; width:593;”><embed src=”http://www.cchrint.org/slideshow/index.html” width=”593″ height=”440″ style=”overflow:hidden; height:440px; width:593;”> </embed>Error: Embedded data could not be displayed.</object>

OR

<iframe src=”http://www.cchrint.org/slideshow/index.html” width=”593″  height=”440″ style=”border:none; overflow:hidden;”></iframe>

RETURN TO BLOGS PAGE


  • Share/Bookmark

New study linking anti-psychotics to brain damage raises alarm bells with health campaigners & human rights groups

Monday, July 19th, 2010

Black Mental Health UK
By Zephaniah Samuels
July 18, 2010

Findings from a new study that shows that anti-psychotic drugs are likely to cause brain damage has raised alarm bells among  health campaigners and human rights groups.

Effects of antipsychotics on brain volume

Entitled ‘A systematic review of the effects of antipsychotic drugs on brain volume ,’ the results of this study dispel the widely-held view that schizophrenia itself causes brain structural changes.  ‘Some evidence points towards the possibility that antipsychotic drugs reduce the volume of brain matter and increase ventricular or fluid volume. Antipsychotics may contribute to the genesis of some of the abnormalities usually attributed to schizophrenia,’ the report says.

Published in the journal of Psychological Medicine these new findings are based on a review of the effects of antipsychotic drugs on the brain. The findings  published earlier this year, have raised alarm among race equality and human rights groups who are increasingly concerned  about the over-diagnosis of  ‘schizophrenia’ among  people from  African Caribbean people communities.

The annual Count Me In Census report logs the ethnic origin of those admitted into psychiatric care including those detained against their will under the Mental Health Act.

For the past four years census findings have shown that rates of forced detention of black people under the Act continue to rise while falling for the rest of the population.  The results of the latest 2009 Census published earlier this year again confirmed health campaigners worst fears, that absolutely no improvement has been made to reduce the detention rate of black people sectioned under the Mental Health Act despite the former government’s million pound programmed to address the racism and  within mental health service.

African Caribbean’s routinely given diagnosis of schizophrenia

Once in the system evidence shows that black people are routinely given a diagnosis of schizophrenia even though there is no biological evidence to show that this group have higher rates of mental ill health than their white counter parts.

The diagnosis of schizophrenia is routinely accompanied by a regime of antipsychotic medication, with little evidence of those who enter the system ever making a full recovery.

A report by the now defunct Mental Health Act Commission  entitled, Risks, Rights and Recovery published in 2008 show that over stretched staff are regularly  give patients high doses of medication in order to make patients more easy to manage.

This latest paper challenges the view that schizophrenia itself causes brain structural changes, such as less brain grey matter, larger ventricles and more cerebrospinal fluid (CSF) spaces, researchers say.  The team responsible for this work reviewed magnetic resonance imaging studies, which had assessed brain changes in patient on anti-psychotic and those of patients not on the drugs.

Over half of the 26 studies showed that the brains of patients on anti-psychotics had shrunk. This was compared to the 21 studies of patients who had not be given anti-psychotics, where just five showed brain size decreases.  However no differences were reported in three studies of non-drug patients who had been ill for a long time.

Read entire article:  http://www.blackmentalhealth.org.uk/index.php?option=com_content&task=view&id=805&Itemid=117

« Return to news items


  • Share/Bookmark